Netherlands· NL-b866ec24f830
Barnidipine HCl Sigillata 20 mg, harde capsules met gereguleerde afgifte
A barnidipine product containing barnidipinehydrochloride, registered in Netherlands by Sigillata Limited. The same ATC class is registered in 6 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Barnidipine is registered in 6 of 19 countries.
Countries holding a registration under ATC C08CA12 (barnidipine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Barnidipine · ATC C08CA12
6 / 19 countries
- Belgiumprice
- Italyprice
- Japan
- Netherlands
- Polandprice
- Spainprice
Price per daily dose
What a daily dose of barnidipine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.26 in Italy to $0.43 in Spain — a ×1.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Barnidipine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- ES Spain$0.43
- IT Italy$0.26
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BARNIDIPINEHYDROCHLORIDE
- Manufacturer
- Sigillata Limited
- Country
- Netherlands (NL)
- ATC code
- C08CA12
- ATC class
- Barnidipine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- July 21, 2026
Packs & prices · 1
- cbg_meb_id127088
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Barnidipine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBARNIDIPINO SWANPOND INVESTMENTS 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFGSwan Pond Investments Limited
- BelgiumVasexten 20 20 mgImpexeco
- ItalyBARNIDIPINA CLORIDRATO TEVATEVA B.V.
- PolandBarnidipine TevaTeva B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Spain · Barnidipino Teva, Barnix
- Italy · Barnidipina Cloridrato Teva, Libradin
- Poland · Barnidipine Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b91e18c3-41c8-49da-b4f4-78db660400be GET /v1/drugs/b91e18c3-41c8-49da-b4f4-78db660400be?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule met gereguleerde afgifte, hard",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127088_smpc_en.pdf",
"strength": null,
"atc_label": "Barnidipine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127088",
"excipients": [
"AMMONIA (E 527)",
"CARMELLOSE (E 466)",
"ETHYLCELLULOSE (E 462)",
"GELATINE (E 441)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ZWART (E 172)",
"KALIUMHYDROXIDE (E 525)",
"MAÏSZETMEEL",
"POLYSORBAAT 80 (E 433)",
"PROPYLEENGLYCOL (E 1520)",
"SACCHAROSE",
"SCHELLAK (E 904)",
"SUIKERZETMEELBOLLETJES",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"ZWARTE INKT"
],
"substances": [
"BARNIDIPINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127088_piluk.pdf",
"authorised_at": "2022/04/26",
"procedure_number": "NL/H/5243/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "127088",
"additional_monitoring": "N"
}See everything about barnidipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.